Related Experiment Video
Updated: Aug 20, 2026

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
Published on: March 18, 2014
Non-heparan sulfate-binding interactions of endostatin/collagen XVIII in murine development
Natalia Rychkova1, Sonja Stahl, Sabine Gaetzner
1Department of Human Genetics, University of Würzburg, Biozentrum, Am Hubland, D-97074 Würzburg, Germany.
Abstract:
Knobloch syndrome is characterized by a congenital generalized eye disease and cranial defect. Pathogenic mutations preferentially lead to a deletion or functional alteration of collagen XVIII's most C-terminal endostatin domain. Endostatin can be released from collagen XVIII and is a potent inhibitor of angiogenesis and tumor growth. We show differential expression of binding partners for endostatin, vascular endothelial growth factor (VEGF), and the collagen XV endostatin homologue in murine embryonal development using a set of alkaline phosphatase fusion proteins. Consistent with the human phenotype, vascular mesenchyme in the developing eye was identified as endostatin's primary target. While endostatin predominantly bound to blood vessels, the VEGF164 affinity probe labeled nonvascular tissues such as forebrain, hindbrain, the optic nerve, and the surface ectoderm of the future cornea. Strikingly increased staining specificity was observed with a non-heparin/heparan sulfate-binding endostatin probe. In contrast, elimination of the heparan sulfate binding site from VEGF led to complete loss of binding. The collagen XV endostatin homologue showed a highly restricted binding pattern. Oligomerization with endogenous endostatin was ruled out by use of collagen XVIII knockout mice. Our data provide strong evidence that collagen XVIII's C-terminal endostatin domain harbors a prominent tissue-binding site and that binding can occur in the absence of heparan sulfates in situ.
Insights
Knobloch syndrome involves eye and cranial defects due to collagen XVIII mutations. Endostatin, a collagen XVIII domain, binds to developing eye blood vessels, influencing disease pathology.
Area of Science:
- Developmental Biology
- Molecular Biology
- Genetics
Background:
- Knobloch syndrome is linked to mutations in collagen XVIII, affecting its C-terminal endostatin domain.
- Endostatin is a known inhibitor of angiogenesis and tumor growth, suggesting a role in vascular development.
Purpose of the Study:
- To investigate the binding partners and tissue distribution of endostatin and related molecules during embryonic development.
- To elucidate the role of collagen XVIII's endostatin domain in the pathogenesis of Knobloch syndrome.
Main Methods:
- Utilized alkaline phosphatase fusion proteins to create affinity probes for endostatin, vascular endothelial growth factor (VEGF), and collagen XV.
- Examined binding patterns in murine embryonal development, including collagen XVIII knockout mice.
- Assessed the role of heparan sulfate binding sites in molecular interactions.
Main Results:
- Endostatin predominantly binds to vascular mesenchyme in the developing eye, consistent with Knobloch syndrome phenotypes.
- VEGF164 binds to both vascular and non-vascular tissues, including the developing brain and cornea.
- A modified endostatin probe lacking heparan sulfate binding showed enhanced specificity, while VEGF binding was abolished without its binding site.
Conclusions:
- The C-terminal endostatin domain of collagen XVIII possesses a significant tissue-binding site.
- Endostatin binding to ocular vasculature is crucial in Knobloch syndrome, and this interaction can occur independently of heparan sulfates.
- Differential binding of endostatin and VEGF highlights their distinct roles in embryonic development.
Related Concept Videos
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to form...
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can exist in...

